Bain-Backed Emcure Pharmaceuticals Eyes $672 Million IPO � Source

[email protected]06 Sep, 2021News

BENGALURU (Reuters) -India's Emcure Pharmaceuticals has filed draft papers with the market regulator for an initial public offering, which a source with direct knowledge of the matter said could be worth up to 50 billion rupees ($671.89 million). Emcure is the latest Indian company to tap capital markets this year in a fund-raising frenzy driven by abundant liquidity and record-high stock markets.